Surgery Partners [SGRY] vs HCA Healthcare [HCA] Detailed Stock Comparison
Surgery Partners
NASDAQ
Loading...
HCA Healthcare
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Surgery Partners wins in 2 metrics, HCA Healthcare wins in 17 metrics, with 0 ties. HCA Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Surgery Partners | HCA Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 2,956.00 | 18.04 | HCA Healthcare |
| Price-to-Book Ratio | 1.54 | -81.93 | HCA Healthcare |
| Debt-to-Equity Ratio | 108.74 | -37.45 | HCA Healthcare |
| PEG Ratio | -35.47 | 0.72 | Surgery Partners |
| EV/EBITDA | 12.66 | 10.28 | HCA Healthcare |
| Profit Margin (TTM) | -5.57% | 8.21% | HCA Healthcare |
| Operating Margin (TTM) | 14.68% | 15.95% | HCA Healthcare |
| EBITDA Margin (TTM) | 14.68% | 15.95% | HCA Healthcare |
| Return on Equity | 0.12% | 13,631.68% | HCA Healthcare |
| Return on Assets (TTM) | 3.92% | 11.84% | HCA Healthcare |
| Free Cash Flow (TTM) | $209.70M | $5.64B | HCA Healthcare |
| Dividend Yield | N/A | 0.54% | N/A |
| 1-Year Return | -33.06% | 9.89% | HCA Healthcare |
| Price-to-Sales Ratio (TTM) | 0.84 | 1.38 | Surgery Partners |
| Enterprise Value | $8.17B | $148.99B | HCA Healthcare |
| EV/Revenue Ratio | 2.52 | 2.05 | HCA Healthcare |
| Gross Profit Margin (TTM) | 23.67% | 40.97% | HCA Healthcare |
| Revenue per Share (TTM) | $26 | $292 | HCA Healthcare |
| Earnings per Share (Diluted) | $-1.43 | $23.81 | HCA Healthcare |
| Beta (Stock Volatility) | 1.84 | 1.41 | HCA Healthcare |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Surgery Partners vs HCA Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Surgery Partners | -3.59% | -6.94% | -7.65% | -7.44% | -0.59% | -4.23% |
| HCA Healthcare | 0.93% | 3.00% | 3.70% | 14.40% | 31.53% | 45.61% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Surgery Partners | -33.06% | -17.62% | -13.75% | 7.49% | 10.63% | 10.63% |
| HCA Healthcare | 9.89% | 115.19% | 220.86% | 494.31% | 1,293.16% | 1,293.16% |
News Based Sentiment: Surgery Partners vs HCA Healthcare
Surgery Partners
News based Sentiment: NEUTRAL
Surgery Partners reported solid revenue growth and reaffirmed its guidance, but profitability remains a concern. Regulatory changes introduce both opportunities and challenges, creating a balanced investment picture. The upcoming Investor Day will be crucial for clarifying the company's strategy and outlook.
HCA Healthcare
News based Sentiment: MIXED
HCA Healthcare reported strong Q2 2025 results and is expanding its operations, but faces regulatory challenges and mixed investor sentiment. While analysts generally maintain positive ratings, insider selling and slowing outpatient growth introduce caution, creating a mixed investment narrative.
Performance & Financial Health Analysis: Surgery Partners vs HCA Healthcare
| Metric | SGRY | HCA |
|---|---|---|
| Market Information | ||
| Market Cap | $2.80B | $100.93B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 1,195,740 | 1,035,510 |
| 90 Day Avg. Volume | 1,294,510 | 1,206,980 |
| Last Close | $20.39 | $433.55 |
| 52 Week Range | $18.87 - $33.37 | $289.98 - $435.03 |
| % from 52W High | -38.90% | -0.34% |
| All-Time High | $69.58 (Jun 21, 2021) | $435.03 (Oct 06, 2025) |
| % from All-Time High | -70.70% | -0.34% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.06% |
| Quarterly Earnings Growth | 0.08% | 0.13% |
| Financial Health | ||
| Profit Margin (TTM) | -0.06% | 0.08% |
| Operating Margin (TTM) | 0.15% | 0.16% |
| Return on Equity (TTM) | 0.00% | 136.32% |
| Debt to Equity (MRQ) | 108.74 | -37.45 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $13.73 | $-18.61 |
| Cash per Share (MRQ) | $1.96 | $4.45 |
| Operating Cash Flow (TTM) | $263.90M | $11.93B |
| Levered Free Cash Flow (TTM) | $162.32M | $5.59B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.54% |
| Last 12-Month Dividend | N/A | $2.04 |
Valuation & Enterprise Metrics Analysis: Surgery Partners vs HCA Healthcare
| Metric | SGRY | HCA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 2,956.00 | 18.04 |
| Forward P/E | 16.79 | 17.50 |
| PEG Ratio | -35.47 | 0.72 |
| Price to Sales (TTM) | 0.84 | 1.38 |
| Price to Book (MRQ) | 1.54 | -81.93 |
| Market Capitalization | ||
| Market Capitalization | $2.80B | $100.93B |
| Enterprise Value | $8.17B | $148.99B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.52 | 2.05 |
| Enterprise to EBITDA | 12.66 | 10.28 |
| Risk & Other Metrics | ||
| Beta | 1.84 | 1.41 |
| Book Value per Share (MRQ) | $13.73 | $-18.61 |
Financial Statements Comparison: Surgery Partners vs HCA Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SGRY | HCA |
|---|---|---|
| Revenue/Sales | $776.00M | $18.61B |
| Cost of Goods Sold | $614.10M | $10.98B |
| Gross Profit | $161.90M | $7.62B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $89.60M | $2.97B |
| EBITDA | $131.50M | $3.85B |
| Pre-Tax Income | $-300,000 | $2.42B |
| Income Tax | $0 | $524.00M |
| Net Income (Profit) | $-300,000 | $1.89B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SGRY | HCA |
|---|---|---|
| Cash & Equivalents | $229.30M | $1.06B |
| Total Current Assets | $1.07B | $16.26B |
| Total Current Liabilities | $569.40M | $13.63B |
| Long-Term Debt | $3.72B | $42.92B |
| Total Shareholders Equity | $3.59B | $-438.00M |
| Retained Earnings | $-775.00M | $-3.16B |
| Property, Plant & Equipment | $2.02B | $65.81B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SGRY | HCA |
|---|---|---|
| Operating Cash Flow | $-1.50M | $2.65B |
| Capital Expenditures | $-17.90M | $-991.00M |
| Free Cash Flow | $-16.70M | $660.00M |
| Debt Repayment | $-119.30M | $-3.90B |
| Common Stock Repurchase | N/A | $-2.51B |
Short Interest & Institutional Ownership Analysis
| Metric | SGRY | HCA |
|---|---|---|
| Shares Short | 13.22M | 4.23M |
| Short Ratio | 10.18 | 3.66 |
| Short % of Float | 0.22% | 0.03% |
| Average Daily Volume (10 Day) | 1,195,740 | 1,035,510 |
| Average Daily Volume (90 Day) | 1,294,510 | 1,206,980 |
| Shares Outstanding | 127.11M | 249.98M |
| Float Shares | 68.52M | 162.19M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 1.14% | 0.63% |
Dividend Analysis & Yield Comparison: Surgery Partners vs HCA Healthcare
| Metric | SGRY | HCA |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.04 |
| Last 12-Month Dividend Yield | N/A | 0.54% |
| 3-Year Avg Annual Dividend | N/A | $2.29 |
| 3-Year Avg Dividend Yield | N/A | 0.22% |
| 3-Year Total Dividends | N/A | $6.88 |
| Ex-Dividend Date | N/A | Mar 17, 2025 |